TuHURA Biosciences, Inc./NV SEC filings HURA
TuHURA Biosciences, Inc./NV has 928 filings in SEC EDGAR's recent list, going back to Aug 17, 2010. Its latest annual report, Form ARS, was filed on Jul 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jul 9, 2026 | — |
| DEF 14A | Proxy statement | Jul 9, 2026 | Aug 18, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 26, 2026 | Aug 18, 2026 |
| DEF 14A | Proxy statement | May 17, 2024 | Jun 20, 2024 |
| DEF 14A | Proxy statement | Sep 11, 2023 | Oct 9, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 1, 2023 | Oct 9, 2023 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 31, 2023 | May 8, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 21, 2023 | May 8, 2023 |
| DEFA14A | Additional proxy material | May 6, 2022 | — |
| DEF 14A | Proxy statement | May 6, 2022 | Jun 21, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2022 | Jun 21, 2022 |
| DEF 14A | Proxy statement | May 7, 2021 | Jun 25, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 27, 2021 | Jun 25, 2021 |
| DEFA14A | Additional proxy material | Jun 11, 2020 | — |
| DEFA14A | Additional proxy material | Jun 8, 2020 | — |
| DEF 14A | Proxy statement | Jun 2, 2020 | Jun 26, 2020 |
| DEF 14A | Proxy statement | May 14, 2019 | Jun 26, 2019 |
| PRE 14A | Preliminary proxy statement | May 3, 2019 | May 3, 2019 |
| DEF 14A | Proxy statement | Mar 9, 2018 | Mar 12, 2018 |
| PRE 14A | Preliminary proxy statement | Feb 22, 2018 | Feb 22, 2018 |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1498382
- Former names
- Kintara Therapeutics, Inc. (until Oct 22, 2024); DelMar Pharmaceuticals, Inc. (until Aug 18, 2020); Berry Only Inc. (until Jan 18, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.